PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)

Analysis

PROCEPT BioRobotics (PRCT) Net Income towards Common Stockholders Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 24.56%
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 22.97%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 20.02%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 51.47%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -7.83%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 29.05%
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 17.54%
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn -0.34%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.34%
Mar 31, 2026 -2.64%
Dec 31, 2025 -7.22%
Sep 30, 2025 -0.77%
Jun 30, 2025 -0.45%
Mar 31, 2025 -13.04%
Dec 31, 2024 -4.21%
Sep 30, 2024 -18.21%
Jun 30, 2024 -23.95%
Mar 31, 2024 -30.85%
Dec 31, 2023 -27.00%
Sep 30, 2023 -29.14%